RealClearHealth January 11, 2016 Archives

RealClearHealth AM Update

Congress May Take On Inversions

Mary Ellen McIntire Morning Consult

Drugmakers Raise Prices Despite Criticisms

Peter Loftus W.S. Journal

Pfizer Hikes Prices for Over 100 Drugs on Jan. 1

Deena Beasley Reuters

How Valeant Doubled Sales of Old Drug

Weinberg & Langreth Bloomberg

Big Insurer Defections Signal AHIP's Fading Clout

Bob Herman MH

Doctors Unionize to Resist the Medical Machine

Noam Scheiber NYT

Tax Error Complicates Insurance Subsidies

Ricardo Alonso-Zaldivar AP

Senate Dems Call to Revisit Gun Violence Research

Jordain Carney Hill

NIH Tries to Avoid Ghosts of Its Past

Sheila Kaplan Stat

Adding the Patient Voice to Drug Development

Sarah Karlin Politico

Study Links ADHD and Even 'Safe' Lead Levels

Lynne Terry Oregonian

States Urged to Scrutinize Insurance Mega-Mergers

Chad Terhune LAT

Governors Get Smarter on Medicaid

New York Times

Case Threatens To Sink Price Transparency

Yevgeniy Feyman Apothecary

No More Excuses on the HIV/AIDS Pandemic

Anthony S. Fauci WP

RealClearHealth PM Update

Insurers Say Special Enrollment Drives Cost Growth

Robert Pear NYT

UPMC, Health Catalyst Partner on Cost Management

Kris Mamula PPG

NIH Asked to Override Drug Patents

Ed Silverman Pharmalot

Will Wearables Add Up to Healthier Living?

Miles O'Brien NewsHour

Encouraging Investment in Medicaid Info Tech

Andy Slavitt CMS Blog

Incentives for Hospitals May Harm Patients

Des Moines Register

7 Things to Know about Obamacare Enrollment

Brian Blase Apothecary

Even a GOP President Might Not Kill Obamacare

Jill Lawrence USAT